Fcgr2b-Fcgr3-Fcgr4-KO/hPD-1

品系全名

C57BL/6JSmo-Fcgr2bem1Fcgr3em1Fcgr4em1Pdcd1em1(hPDCD1)Smoc

目录号

NM-KO-220068

品系状态

精子冻存

导出PDF

基因信息

基因名
Fcgr2b

品系描述

在hPD-1(NM-HU-00015)的背景上,敲除从Fcgr3基因的上游到Fcgr2b基因的3’UTR之间的所有序列,获得Fcgr2b-Fcgr3-Fcgr4-KO/hPD-1小鼠模型。
应用领域:免疫治疗,肿瘤研究,药物筛选

你也可能感兴趣

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

查看

Workshop:Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

查看

Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

查看